Disclosure: We earn commissions on purchases made through our links. This never influences our scores. Editorial policy
Echinacea
Echinacea is one of the most-studied herbals in the world, and the trial record is honestly split.
- Evidence
- Mixed Evidence
- Category
- Immune Support
- Best form
- Echinaforce (A.Vogel fresh-pressed E. purpurea aerial + root liquid extract, the most studied single product)
- Effective dose
- 2,400-4,000mg/day of E. purpurea aerial extract (Echinaforce-style fresh-pressed dose) or 600-900mg/day of E. angustifolia or E. purpurea root extract
- Lab tested
- 3 of 8 products
- Category
- Immune Support
- Best form
- Echinaforce (A.Vogel fresh-pressed E. purpurea aerial + root liquid extract, the most studied single product)
- Effective dose
- 2,400-4,000mg/day of E. purpurea aerial extract (Echinaforce-style fresh-pressed dose) or 600-900mg/day of E. angustifolia or E. purpurea root extract
- Lab tested
- 3 of 8 products
Key takeaways
- →Mixed evidence overall: a major meta-analysis shows real benefit, the Cochrane review finds little, and the difference is mostly which product was tested.
- →Echinaforce (fresh-pressed E. purpurea, 2,400mg/day) has the cleanest positive data; generic dried-root capsules are not interchangeable.
- →Use prophylactically through cold season rather than as a 3-day rescue at symptom onset; expect a modest effect at best.
- →Avoid if you have an autoimmune condition, ragweed or daisy allergy, or take immunosuppressants; not well-studied in pregnancy or kids.
What Is Echinacea?
Echinacea is one of the most-studied herbals in the world, and the trial record is honestly split. The Shah 2007 Lancet Infectious Diseases meta-analysis of 14 trials found echinacea cut the odds of catching a cold by 58 percent and shortened cold duration by about 1.4 days. The 2014 Karsch-Volk Cochrane review, with 24 trials and 4,631 participants, was much more sober: trends toward prevention but nothing that cleared statistical significance, and treatment effects too small to call clinically useful. Both reviews are looking at echinacea, but they are not looking at the same product. That is the whole story.
The species and preparation matter more than the dose. There are three plants on the market sold as "echinacea": E. purpurea (the whole flowering plant, roots included), E. angustifolia (root only, narrower-leaf species), and E. pallida (root, less common). Within each species, you can buy expressed juice, alcohol tincture, dried powder, or standardized extract, and each has a different chemistry. The Sperber 2004 trial in Clinical Infectious Diseases used an unstandardized E. purpurea preparation against a rhinovirus challenge and found nothing. The Turner 2005 NEJM trial used three different E. angustifolia root extracts against rhinovirus challenge and also found nothing. Both got heavy press and pulled industry attention away from the category. Meanwhile the Jawad 2012 trial of Echinaforce (A.Vogel's fresh-pressed E. purpurea preparation, 2,400mg/day for four months) on 755 healthy adults found significant reductions in cold episodes and virally confirmed colds.
Prophylactic versus therapeutic also matters. The longer studies that dosed daily through cold season tend to show prevention signals. Studies that wait until symptoms start and dose for 5-10 days show smaller and less consistent effects on duration. For pediatric use, the Taylor 2003 JAMA trial of E. purpurea in kids 2-11 found no effect on URI duration and a higher rate of rash than placebo, which is a real concern for parents.
What you can take from this: if you want to try echinacea, use Echinaforce (or a fresh-pressed E. purpurea aerial-parts equivalent) at the studied 2,400-4,000mg/day dose, and treat it as a prophylactic taken through cold season rather than a 3-day rescue at symptom onset. Generic dried-root capsules at 400mg are not the same product the trials tested, and the negative trials should temper expectations even with the right preparation.
Does It Work? The Evidence
How A-F grades workPrevention of common cold (incidence reduction)
Shah et al. 2007 Lancet Infect Dis meta-analysis (PMID 17597571): 58% reduced odds of cold across 14 trials; Jawad et al. 2012 RCT (PMID 23024696, n=755) of Echinaforce: significantly fewer cold episodes over 4 months; Karsch-Volk 2014 Cochrane (PMID 24554461): non-significant prevention trend across 24 trials
Shorter duration of common cold
Shah et al. 2007 meta-analysis: weighted mean reduction of 1.4 days; Karsch-Volk 2014 Cochrane: pooled treatment effect not statistically significant; effect size depends heavily on species and preparation
Prevention of experimental rhinovirus infection (challenge studies)
Sperber et al. 2004 Clin Infect Dis (PMID 15156472, n=48) using unstandardized E. purpurea: no significant effect; Turner et al. 2005 NEJM (PMID 16049208, n=437) testing three E. angustifolia root extracts: no effect on infection rate or symptom severity
Treatment of upper respiratory infection in children
Taylor et al. 2003 JAMA (PMID 14657066, n=407 kids 2-11) using E. purpurea aerial extract: no effect on URI duration or severity, with higher rash rate than placebo (7.1% vs 2.7%)
Direct antiviral activity (in vitro)
Cell-culture work shows alkamides and chicoric acid can interfere with viral entry and inflammatory cytokine release, but human pharmacokinetic translation is unclear
| Grade | Claimed Benefit | Key Studies | Our Verdict |
|---|---|---|---|
| B | Prevention of common cold (incidence reduction) | Shah et al. 2007 Lancet Infect Dis meta-analysis (PMID 17597571): 58% reduced odds of cold across 14 trials; Jawad et al. 2012 RCT (PMID 23024696, n=755) of Echinaforce: significantly fewer cold episodes over 4 months; Karsch-Volk 2014 Cochrane (PMID 24554461): non-significant prevention trend across 24 trials | Conflicted |
| B | Shorter duration of common cold | Shah et al. 2007 meta-analysis: weighted mean reduction of 1.4 days; Karsch-Volk 2014 Cochrane: pooled treatment effect not statistically significant; effect size depends heavily on species and preparation | Early Signal |
| B | Prevention of experimental rhinovirus infection (challenge studies) | Sperber et al. 2004 Clin Infect Dis (PMID 15156472, n=48) using unstandardized E. purpurea: no significant effect; Turner et al. 2005 NEJM (PMID 16049208, n=437) testing three E. angustifolia root extracts: no effect on infection rate or symptom severity | Ineffective |
| C | Treatment of upper respiratory infection in children | Taylor et al. 2003 JAMA (PMID 14657066, n=407 kids 2-11) using E. purpurea aerial extract: no effect on URI duration or severity, with higher rash rate than placebo (7.1% vs 2.7%) | Ineffective |
| C | Direct antiviral activity (in vitro) | Cell-culture work shows alkamides and chicoric acid can interfere with viral entry and inflammatory cytokine release, but human pharmacokinetic translation is unclear | Not There Yet |
How to Choose: Forms, Doses & What Matters
Clinical dose: 2,400-4,000mg/day of E. purpurea aerial extract (Echinaforce-style fresh-pressed dose) or 600-900mg/day of E. angustifolia or E. purpurea root extract; liquid drops dose differently
Best forms: Echinaforce (A.Vogel fresh-pressed E. purpurea aerial + root liquid extract, the most studied single product), Standardized E. purpurea aerial-parts extract (whole herb, not just root), E. angustifolia root extract (used in older trials but variable across brands)
For prophylactic use through cold season, take 2,400mg/day of an Echinaforce-style fresh-pressed E. purpurea extract (typically split into 3 doses), or 600-900mg/day of a standardized root extract. Most positive prevention trials dosed continuously for 8-16 weeks. For acute use at symptom onset, dose at the higher end (up to 4,000mg/day of fresh-pressed extract or 20-25 drops of liquid tincture 3-5 times daily) for 5-10 days starting at the first sign of symptoms. With liquid extracts, follow the bottle's drop count and frequency - drops are not directly comparable to capsule milligrams. Take with water; food helps with the GI upset that some people get on alcohol-based tinctures.
Who Should Take Echinacea?
Adults who get frequent colds and want a prophylactic herbal option through cold and flu season, ideally using Echinaforce or an equivalent fresh-pressed E. purpurea preparation. People who prefer a daily preventive approach over reactive symptom-onset dosing. Anyone willing to commit to 8-16 weeks of daily use to give the prevention effect a chance, since most positive trials ran 4 months.
Who Should Avoid It?
Not for everyone
Side Effects & Safety
Product Scores
8 products scored on dosing accuracy, third-party testing, cost per effective dose, and label transparency.
The Scorecard: 8 Products Compared
Echinaforce Liquid Extract Drops 1.7oz
A.Vogel
$22.99 ÷ 74 days at 20drops/day (1 serving × 20drops)
If you want the product the positive trial evidence is actually based on, this is it
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Super Echinacea Liquid Extract 1oz
Herb Pharm
$14.99 ÷ 33 days at 30drops/day (1 serving × 30drops)
The closest US-domestic stand-in for an Echinaforce-style whole-plant fresh extract
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Echinaforce Tablets 120ct
A.Vogel
$19.99 ÷ 14 days at ~2305mg/day (2.9 servings × 800mg)
The tablet alternative for people who do not want an alcohol tincture
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Echinacea Purpurea Herb 400mg 180ct
Nature's Way
$12.99 ÷ 31 days at 2400mg/day (2 servings × 1200mg)
If you want a budget aerial-parts E. purpurea capsule with botanical-identity testing, this is the pick
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Echinacea (Purpurea Root) 400mg 250ct
NOW Foods$14.99 ÷ 43 days at ~2335mg/day (5.8 servings × 400mg)
Cheapest entry point in the category; quality is reasonable for the price but the format is the weakest-evidence one
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Echinacea Supreme Liquid Phyto-Caps 60ct
Gaia Herbs$24.99 ÷ 9 days at ~2303mg/day (3.3 servings × 700mg)
Best for buyers who care about traceability and would rather avoid alcohol tinctures, accepting the higher price
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Echinacea Purpurea & Angustifolia Root 460mg 180ct
Solaray
$14.99 ÷ 36 days at ~2320mg/day (2.5 servings × 920mg)
Reasonable price for a two-species root capsule; format does not match the positive-trial evidence
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Echinacea 400mg 100ct
Nature's Bounty
$7.49 ÷ 17 days at ~2296mg/day (5.7 servings × 400mg)
The drugstore default; fine if you want to try echinacea cheaply, but not the format the trials used
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Full Comparison
| Category | Echinaforce Liquid Extract Drops 1.7oz A.Vogel | Super Echinacea Liquid Extract 1oz Herb Pharm | Echinaforce Tablets 120ct A.Vogel | Echinacea Purpurea Herb 400mg 180ct Nature's Way | Echinacea (Purpurea Root) 400mg 250ct NOW Foods | Echinacea Supreme Liquid Phyto-Caps 60ct Gaia Herbs | Echinacea Purpurea & Angustifolia Root 460mg 180ct Solaray | Echinacea 400mg 100ct Nature's Bounty |
|---|---|---|---|---|---|---|---|---|
| Brand Score | 89/100Winner | 81/100 | 80/100 | 78/100 | 75/100 | 74/100 | 73/100 | 65/100 |
| Dosing & Form | 25/25Winner | 22/25 | 22/25 | 19/25 | 16/25 | 19/25 | 16/25 | 16/25 |
| Purity | 19/25Winner | 19/25 | 19/25 | 19/25 | 19/25 | 19/25 | 19/25 | 13/25 |
| Value | 22/25Winner | 17/25 | 16/25 | 22/25 | 22/25 | 13/25 | 19/25 | 19/25 |
| Transparency | 23/25Winner | 23/25 | 23/25 | 18/25 | 18/25 | 23/25 | 19/25 | 17/25 |
| Cost/Day | $0.31Winner | $0.45 | $1.44 | $0.42 | $0.35 | $2.74 | $0.42 | $0.43 |
| Dose/Serving | 20drops | 30drops | 800mg | 1200mg | 400mg | 700mg | 920mg | 400mg |
| Form | Fresh-pressed E. purpurea aerial + root liquid extract (alcohol-based tincture) | Whole-plant E. purpurea liquid extract (organic cane alcohol base) | Fresh-pressed E. purpurea extract (tablets) | Dried E. purpurea aerial-parts powder (vegan capsules) | Dried E. purpurea root powder (vegan capsules) | E. purpurea root + E. angustifolia root liquid extract in vegan capsules | Dried E. purpurea root + E. angustifolia root powder (vegan capsules) | Dried E. purpurea aerial-parts powder (gelatin capsules) |
| Third-Party Tested | No | ✓ Yes | No | ✓ Yes | No | ✓ Yes | No | No |
| Proprietary Blend | No | No | No | No | No | No | No | No |
Frequently Asked Questions
Is Echinaforce really better than a generic echinacea capsule?
It has more clinical evidence than any other branded preparation, and the formula is specific: fresh-pressed E. purpurea aerial parts plus root, alcohol-extracted within 24 hours of harvest. The Jawad 2012 trial of 755 adults used Echinaforce specifically and showed reduced cold episodes over 4 months. Generic dried-root capsules at 400mg may not contain the same active alkamides and polysaccharides at the same concentrations. That is not a guarantee that generic capsules do nothing, but it does mean the trial evidence does not directly transfer.
What is the difference between E. purpurea, E. angustifolia, and E. pallida?
Three different plant species sold under the same common name. E. purpurea (purple coneflower) is the most commonly used in commercial supplements and is typically used whole-plant including aerial parts. E. angustifolia is narrower-leaf and historically used root-only - this is the species in the Turner 2005 NEJM rhinovirus trial that found no effect. E. pallida is less common and almost always sold as root tincture. Their alkamide and polysaccharide profiles differ enough that trial results from one do not necessarily apply to the others. Most product labels do specify the species somewhere on the bottle - if yours does not, that is a warning sign.
Should I take echinacea to prevent colds or only when I feel one coming on?
The prevention data is more consistent than the treatment data. The Jawad 2012 Echinaforce trial dosed continuously for 4 months and showed fewer cold episodes overall. Studies that started dosing at symptom onset show smaller and less consistent effects on cold duration. If you only take it for 3 days when you feel sick, you are running the lowest-evidence version of the protocol. Daily dosing through cold season has the best support, even if the effect size is still modest.
Is echinacea safe for children?
The Taylor 2003 JAMA trial of E. purpurea in kids ages 2-11 found no benefit on URI duration and a higher rate of rash than placebo (7.1% vs 2.7%). That is a real safety signal in a population that already has plenty of allergic reactions. Most clinicians do not recommend echinacea for children under 12, and it is reasonable to skip it altogether in that group given the lack of efficacy data alongside the rash risk.
Can I take echinacea long-term?
The Jawad 2012 trial dosed Echinaforce continuously for 4 months without serious safety signals, which is the longest controlled human safety data we have. Older recommendations to limit use to 8-10 weeks at a time were based on theoretical immune-tolerance concerns that have not been clearly demonstrated in trials. If you have an autoimmune condition or take any immunomodulating drug, do not take it long-term (or at all) without checking with your doctor.
Does echinacea interact with medications?
Echinacea can inhibit certain cytochrome P450 enzymes (mainly CYP1A2 and CYP3A4 at high doses), which means it can theoretically affect blood levels of drugs metabolized by those pathways - including some statins, certain antidepressants, and immunosuppressants like cyclosporine and tacrolimus. The clinical magnitude of these interactions is usually small but can matter for narrow-therapeutic-index drugs. If you take immunosuppressants for transplant or autoimmune disease, do not take echinacea.
I am allergic to ragweed. Can I take echinacea?
Probably not. Echinacea is in the Asteraceae (Compositae) family along with ragweed, marigolds, daisies, and chrysanthemums. Cross-reactivity is well-documented and can range from mild rash to (rarely) anaphylaxis. Ragweed-allergic users should avoid echinacea or test a very small dose under medical supervision before any regular use.
Sources
- Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. 2007;7(7):473-80.
- Karsch-Volk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2014;(2):CD000530.
- Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med. 2012;2012:841315.
- Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto AS. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin Infect Dis. 2004;38(10):1367-71.
- Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med. 2005;353(4):341-8.
- Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. 2003;290(21):2824-30.
- NIH National Center for Complementary and Integrative Health. Echinacea - What You Need to Know.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products discussed on this page are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any supplement regimen.